Alpana Pasricha, M.D.
Nephrology Physician in Tulsa, Oklahoma.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,534 in Nephrology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Alpana Pasricha, M.D. reported a CMS MIPS final score of 51.8/100 - below the 83.1 national average - and filed 2,343 Medicare Part D claims in 2023.
- 51.8/100
- MIPS score · -31 vs avg
- 2K
- Part D claims, 2023
- 92%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Alpana Pasricha, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
52 4th percentile higher than 4% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Alpana Pasricha, M.D. sits
This provider among nephrology physician peers
Across the 2,476 nephrology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Alpana Pasricha, M.D. writes more Part D claims than 80% of them and scores higher on MIPS quality than 14% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one nephrology physician peer from a representative sample of 60; the gold marker is Alpana Pasricha, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Alpana Pasricha, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Alpana Pasricha, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Oklahoma
How Nephrology Physician compares to other specialties among Oklahoma providers
Nephrology Physician ranks #90 among Oklahoma's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Oklahoma provider total, by primary NUCC taxonomy. The highlighted bar is Nephrology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Alpana Pasricha, M.D.'s 2023 MIPS final score plotted against the Nephrology Physician national average
- MIPS Final Score
- 51.8/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Nephrology Physician) - 51.8/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Nephrology Physician US NPIs
51.8/100 MIPS final score - 31.3 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Nephrology Physician. Quality dim: 66.8. Cost dim: 54.3.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Alpana Pasricha, M.D. appears in the CMS NPPES registry as a Nephrology Physician provider holding M.D. credentials at 6465 S YALE AVE STE 401, Tulsa, OK, 74136, with a listed phone of (918) 582-3154. NPI 1801800222 was issued on 07/28/2006.
Medicare Part D records for calendar year 2023 show 2,343 prescription claims written by this provider, covering 289 Medicare beneficiaries and totaling roughly $197K in drug spend, split 8% brand-name and 92% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 51.8/100 for the 2023 performance year (Quality 66.8, Cost 54.3), compared with the national average of 83.1.
Nephrology Physician is a mid-sized specialty nationwide, with 10,534 enrolled providers across 55 states and an average of 1,454 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1801800222 |
|---|---|
| Specialty | Nephrology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 07/28/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Alpana Pasricha, M.D.'s current license status, disciplinary history, and board certifications with the Oklahoma State Board of Medical Licensure in Oklahoma before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1801800222 is the unique 10-digit identifier CMS uses to link Pasricha across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where Alpana Pasricha, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Alpana Pasricha, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.3K
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
8% brand-name claims vs 92% generic, on 2,343 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,317
- Total Day Supply
- 128,145
- Brand vs Generic
- 8% brand / 92% generic
- Brand Drug Cost
- $137K
- Generic Drug Cost
- $60K
- Antibiotic Claims
- 21
Patient Demographics
- Average Patient Age
- 72.7 years
- Avg HCC Risk Score
- 2.89
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 50, 65-74: 95, 75-84: 110, 85+: 34
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Alpana Pasricha, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Torsemide
Torsemide
469 claims
- Telmisartan
Telmisartan
348 claims
- Allopurinol
Allopurinol
191 claims
- Carvedilol 182
Carvedilol
182 claims
- Amlodipine Besylate 171
Amlodipine Besylate
171 claims
- Vitamin D2 136
Vitamin D2
136 claims
- Spironolactone 127
Spironolactone
127 claims
- Losartan Potassium 90
Losartan Potassium
90 claims
| Drug | Claims |
|---|---|
| Torsemide | 469 |
| Telmisartan | 348 |
| Allopurinol | 191 |
| Carvedilol | 182 |
| Amlodipine Besylate | 171 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 136 |
| Spironolactone | 127 |
| Losartan Potassium | 90 |
| Doxazosin Mesylate | 78 |
| Farxiga Dapagliflozin Propanediol | 44 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nephrology Physician Overview
How Alpana Pasricha, M.D. fits within the Nephrology Physician landscape nationally.
Alpana Pasricha, M.D.'s 2,343 claims are above the specialty average of 1,454.
Nearby Nephrology Physician Providers in Oklahoma
Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as Pasricha.
Compare Nephrology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Oklahoma medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Nephrology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Oklahoma
Frequently Asked Questions
What is Alpana Pasricha, M.D.'s specialty? ▼
How much does Alpana Pasricha, M.D. prescribe under Medicare Part D? ▼
What is Alpana Pasricha, M.D.'s Medicare quality score? ▼
Where is Alpana Pasricha, M.D. located? ▼
What is Alpana Pasricha, M.D.'s NPI number? ▼
Does Alpana Pasricha, M.D. prescribe more brand-name or generic drugs? ▼
How many Nephrology Physician providers are there in the US? ▼
What drugs does Alpana Pasricha, M.D. prescribe most often? ▼
Does Alpana Pasricha, M.D. accept Medicare? ▼
How can I verify Alpana Pasricha, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology